bucladesine has been researched along with Acute Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberich Jordà, M; Battista, N; Delwel, R; Löwenberg, B; Maccarrone, M; Rayman, N; Tas, M; van Lom, K; Verbakel, SE | 1 |
| Mondon, CE; Reaven, GM | 1 |
| Heidland, A; Hörl, WH; Münchmeyer, M; Riegel, W; Stepinski, J | 1 |
| Jungermann, K; Kucera, T; Stümpel, F | 1 |
| Brenner, S; Döcke, WD; Oppert, M; Platzer, C; Prösch, S; Reinke, P; Riese, U; Volk, HD | 1 |
| Kakisaka, A; Kasai, S; Mito, M | 1 |
| Kobayashi, T; Koyama, S; Sakai, A; Yoshimura, K | 1 |
| Kakisaka, A; Kasai, S; Sawa, M | 1 |
8 other study(ies) available for bucladesine and Acute Disease
| Article | Year |
|---|---|
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.
Topics: Acute Disease; Arachidonic Acids; Bucladesine; Cannabinoid Receptor Modulators; Cell Differentiation; Cell Movement; Cyclic AMP; Cyclohexanols; Down-Regulation; Endocannabinoids; Glycerides; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Ligands; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Neutrophils; Pertussis Toxin; Receptor, Cannabinoid, CB2; Receptors, Granulocyte Colony-Stimulating Factor | 2004 |
Evaluation of enhanced glucagon sensitivity as the cause of glucose intolerance in acutely uremic rats.
Topics: Acute Disease; Animals; Blood Glucose; Bucladesine; Glucagon; Glucose; Kinetics; Liver; Male; Nephrectomy; Perfusion; Rats; Urea; Uremia | 1980 |
Effect of serine on gluconeogenic ability of hepatocytes in acute uremia.
Topics: Acute Disease; Adenosine Triphosphate; Animals; Bucladesine; Dihydroxyacetone; Epinephrine; Female; Glucagon; Gluconeogenesis; Glucose; In Vitro Techniques; Liver; Oxidation-Reduction; Pyruvates; Rats; Rats, Inbred Strains; Serine; Uremia | 1983 |
Impaired stimulation of intestinal glucose absorption via hepatoenteral nerves in streptozotocin-diabetic rats.
Topics: Acute Disease; Animals; Autonomic Nervous System; Bucladesine; Carbachol; Chronic Disease; Cyclic AMP; Diabetes Mellitus, Experimental; Glucose; In Vitro Techniques; Insulin; Intestinal Absorption; Kidney; Liver; Male; Portal Vein; Rats; Rats, Wistar; Signal Transduction; Tetrodotoxin | 1999 |
Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T-cells.
Topics: Acute Disease; Aged; Bucladesine; Catecholamines; Cell Line; Cyclic AMP Response Element-Binding Protein; Epinephrine; Female; Humans; Interleukin-10; Jurkat Cells; Male; Middle Aged; Monocytes; Myocardial Infarction; Norepinephrine; Promoter Regions, Genetic; Shock, Cardiogenic; T-Lymphocytes; Transcriptional Activation; Transfection | 2000 |
[Protective effects of DBcAMP on acute liver failure induced by D-galactosamine in rats].
Topics: Acute Disease; Adenosine Triphosphate; Animals; Blood Glucose; Bucladesine; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Circulation; Liver Diseases; Liver Function Tests; Male; Necrosis; Rats; Rats, Inbred Strains | 1989 |
Dibutyryl cyclic AMP inhibits acute hypoxic pulmonary vasoconstriction in conscious sheep.
Topics: Acute Disease; Animals; Blood Pressure; Bucladesine; Consciousness; Dinoprost; Drug Synergism; Hemodynamics; Hypoxia; Norepinephrine; Prostaglandins F; Pulmonary Circulation; Vasoconstriction | 1988 |
[Effects of DBcAMP on galactosamine-induced acute liver failure].
Topics: Acute Disease; Animals; Bucladesine; Chemical and Drug Induced Liver Injury; Galactosamine; Male; Rats; Rats, Inbred Strains | 1986 |